Physician profile
Robert L Thomas
NPI 1619978327
$9,208.64
in general payments reported to CMS, 2019-2025
11 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.22 · 2020: $20.25 · 2022: $63.60 · 2023: $22.54 · 2024: $8,955 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Travel and Lodging: $1,404 · Food and Beverage: $690 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Travel and Lodging | $1,403.54 |
| Food and Beverage | $690.29 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,937.53 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $66.50 | 2025 | |
| Amgen INC. | $56.45 | 2019-2022 | |
| Exact Sciences Corporation | $23.01 | 2025 | Cologuard Collection Kit |
| Paratek Pharmaceuticals, INC. | $22.54 | 2023 | Nuzyra |
| Bayer Healthcare Pharmaceuticals INC. | $20.14 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.40 | 2025 | Exparel |
| Polynovo North America LLC | $17.82 | 2024 | Novosorb Btm |
| Innocoll Pharmaceuticals Limited | $17.48 | 2022 | |
| Corcept Therapeutics | $16.77 | 2025 | Korlym |
| Alexion Pharmaceuticals, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.